CAR T-cell therapy for meningioma: Mesothelin emerges as a novel promising target

Journal Article Accepted manuscript CAR T cell therapy for meningioma: mesothelin emerges as a novel promising target Get access Denis Migliorini Denis Migliorini Department of Oncology, University Hospital of GenevaCenter for Translational Research in Onco-Hematology, University of GenevaBrain Tumor and Immune Cell Engineering laboratory, AGORA Cancer Research Center – Lausanne Correspondance. [email protected] Search for other works by this author on: Oxford Academic PubMed Google Scholar Neuro-Oncology, noaf240, https://doi.org/10.1093/neuonc/noaf240 Published: 11 October 2025 Article history Received: 18 September 2025 Accepted: 24 September 2025 Published: 11 October 2025